PRIMPOL and cancer: Our observation that loss of CSB leads to PRIMPOL-mediated unrestrained DNA replication with attendant gap formation upon exposure to a low dose of CPT raises the possibility that cancer cells deficient in CSB may be sensitive to a combination therapy of low CPT dosage and inhibitors directed against gap filling.